A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

PHASE1RecruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 10, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

LY3209590

Administered SC.

Trial Locations (10)

10016

NOT_YET_RECRUITING

NYU Langone, New York

14203

RECRUITING

UBMD Pediatrics, Buffalo

19104

NOT_YET_RECRUITING

Children's Hospital of Philadelphia, Philadelphia

21287

RECRUITING

Johns Hopkins Hospital, Baltimore

30329

RECRUITING

Children's Healthcare of Atlanta - Center for Advanced Pediatrics, Atlanta

31904

RECRUITING

Centricity Research Columbus Endocrinology, Columbus

38115

RECRUITING

Lifedoc Research - Lenox Park Drive, Memphis

90027

RECRUITING

Children's Hospital Los Angeles, Los Angeles

02215

RECRUITING

Joslin Diabetes Center, Boston

45229-3039

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY